START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, and support participation in trials designed around transportation, work ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...

Head and neck squamous cell carcinoma (HNSCC) remains a globally prevalent malignancy with high morbidity and mortality. Despite therapeutic advances, patient outcomes are hindered by tumor ...

The Health Management Academy's executive forum recognized alongside ASCO, AACR, and other leading gatherings in ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the National Comprehensive ...

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.

Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial In this global phase III ...

CLEVELAND — A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University ...

Jody Agena, PharmD, MBA, director of pharmacy operations, Virginia Cancer Specialists, discusses the various responsibilities of the pharmacist within community oncology settings. The clinical ...

Clinical trial datasets are becoming increasingly complex, yet the format of their dissemination remains largely static.1 ...

Dr. Rasha Kelej Continues to Advance Cancer Care in Africa by Providing 269 Oncology Scholarships for 34 African Countries and Beyond ...